Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stepan (SCL) Research & Development (2016 - 2025)

Stepan (SCL) has disclosed Research & Development for 16 consecutive years, with $15.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 13.85% year-over-year to $15.7 million, compared with a TTM value of $59.3 million through Dec 2025, up 6.47%, and an annual FY2025 reading of $59.3 million, up 6.47% over the prior year.
  • Research & Development was $15.7 million for Q4 2025 at Stepan, up from $14.2 million in the prior quarter.
  • Across five years, Research & Development topped out at $17.1 million in Q4 2021 and bottomed at $13.5 million in Q3 2024.
  • Average Research & Development over 5 years is $15.2 million, with a median of $15.1 million recorded in 2021.
  • The sharpest move saw Research & Development dropped 15.49% in 2023, then grew 13.85% in 2025.
  • Year by year, Research & Development stood at $17.1 million in 2021, then dropped by 2.99% to $16.5 million in 2022, then fell by 7.39% to $15.3 million in 2023, then fell by 9.96% to $13.8 million in 2024, then rose by 13.85% to $15.7 million in 2025.
  • Business Quant data shows Research & Development for SCL at $15.7 million in Q4 2025, $14.2 million in Q3 2025, and $14.7 million in Q2 2025.